Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
This week, the wider benefits of weight-loss jabs were in the spotlight ... hard bargain when it comes to paying for drugs risks stifling innovation and investment in the UK’s life sciences ...
Some results have been hidden because they may be inaccessible to you